Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Disregard. Johns Hopkins says it is fake.
Interesting. Note the paragraph about oxygenated water. This popped up on my facebook page:
The following is forwarded from Dr. Irene Ken, whose daughter is an Asst. Prof in infectious diseases at Johns Hopkins University.
“In our community chat, they sent this excellent summary to avoid contagion ??. I share it with you because it is very clear:
* The virus is not a living organism, but a protein molecule (DNA) covered by a protective layer of lipid (fat), which, when absorbed by the cells of the ocular, nasal or buccal mucosa, changes their genetic code. (mutation) and convert them into aggressor and multiplier cells.
* Since the virus is not a living organism but a protein molecule, it is not killed, but decays on its own. The disintegration time depends on the temperature, humidity and type of material where it lies.
* The virus is very fragile; the only thing that protects it is a thin outer layer of fat. That is why any soap or detergent is the best remedy, because the foam CUTS the FAT (that is why you have to rub so much: for 20 seconds or more, to make a lot of foam). By dissolving the fat layer, the protein molecule disperses and breaks down on its own.
* HEAT melts fat; this is why it is so good to use water above 25 degrees Celsius for washing hands, clothes and everything. In addition, hot water makes more foam and that makes it even more useful.
* Alcohol or any mixture with alcohol over 65% DISSOLVES ANY FAT, especially the external lipid layer of the virus.
* Any mix with 1 part bleach and 5 parts water directly dissolves the protein, breaks it down from the inside.
* Oxygenated water helps long after soap, alcohol and chlorine, because peroxide dissolves the virus protein, but you have to use it pure and it hurts your skin.
* NO BACTERICIDE SERVES. The virus is not a living organism like bacteria; they cannot kill what is not alive with anthobiotics, but quickly disintegrate its structure with everything said.
* NEVER shake used or unused clothing, sheets or cloth. While it is glued to a porous surface, it is very inert and disintegrates only between 3 hours (fabric and porous), 4 hours (copper, because it is naturally antiseptic; and wood, because it removes all the moisture and does not let it peel off and disintegrates). 24 hours (cardboard), 42 hours (metal) and 72 hours (plastic). But if you shake it or use a feather duster, the virus molecules float in the air for up to 3 hours, and can lodge in your nose.
* The virus molecules remain very stable in external cold, or artificial as air conditioners in houses and cars. They also need moisture to stay stable, and especially darkness. Therefore, dehumidified, dry, warm and bright environments will degrade it faster.
* UV LIGHT on any object that may contain it breaks down the virus protein. For example, to disinfect and reuse a mask is perfect. Be careful, it also breaks down collagen (which is protein) in the skin, eventually causing wrinkles and skin cancer.
* The virus CANNOT go through healthy skin.
* Vinegar is NOT useful because it does not break down the protective layer of fat.
* NO SPIRITS, NOR VODKA, serve. The strongest vodka is 40% alcohol, and you need 65%.
* The more confined the space, the more concentration of the virus there can be. The more open or naturally ventilated, the less.
* This is super sad, but you have to wash your hands before and after touching mucosa, food, locks, knobs, switches, remote control, cell phone, watches, computers, desks, TV, etc. And when using the bathroom.
* You have to MOISTURIZE. HANDS DRY from so much washing, and the molecules can hide in the micro cracks. The thicker the moisturizer, the better.
* Also keep your NAILS SHORT so that the virus does not hide there.”
Feel free to share
Awesome. Congrats to Rockwell. I got out at 2.75. Took my profit. Long term looks good for them. Watching closely the MRAG situation.
nice. Did they get the approval?
Quote from Brian Goodman on the Golden Matrix Group, Inc facebook page:
Below is a link to an article out on #WSJ
https://bit.ly/2Uyp8jx
CEO, Brian Goodman said, “I strongly believe there will be a major Paradigm shift in the Casino Industry. The best lifeline to land based casinos in the USA will be a relaxation of #onlinegaming regulations to allow #casinos to offer more traditional table games online. This will also benefit all the states as they will derive taxes from this activity."
That was me again. 250,000 to get to a million total. I have 4,000 at risk on a sub penny company that reports a profit and solid rev growth and low overhead, has the 2018 k audited, the ceo does a conference call and doesn't do any hype at all..if anything he was downright folksy. It is all good. Upside is unlimited and downside is 4g's. True the ss is high but let's get a buy back going. Love it.
Yes. Recurring licensing fees that just keeps growing and growing as they add users. Awesome.
Thanks. Very interesting.
Went ahead and bought another 250,000 shares.
MRAG fires back:
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group, LLC (MRAG), an investment company focused on facilitating the advancement of innovative healthcare companies, intends to ensure Rockwell Medical, Inc. (RMTI; NASDAQ) shareholders will not have their voting rights suppressed by the Rockwell Board of Directors, and intends to use all means available, including litigation, to protect the Rockwell shareholder’s right to vote for new, independent directors and improved, transparent Board governance.
On March 4, 2020, prior to a phone conference with Rockwell’s Chairman of the Board, John McLaughlin, MRAG submitted the necessary documents for their three new directors to be nominated for election at Rockwell’s next annual meeting, and after receiving confirmation from Rockwell prior to the March 8, 2020 deadline of receipt of the nomination materials, the Company waited until after the nomination deadline to note its technical objections to MRAG’s nominations and has since publicly stated that they intend not to recognize the MRAG submission. MRAG feels strongly that the current Rockwell Board of Directors (consisting of John McLaughlin, Stuart Paul, Russell Ellison, Lisa Colleran, John Cooper and Mark Ravich) are attempting to entrench and enrich themselves by trying to prevent and “suppress” RMTI shareholders' right to consider MRAG’s slate of new, independent directors at the Company’s next annual shareholder meeting.
On February 24, 2020, MRAG offered Rockwell and the Board of Directors $15 million for equity priced at the market on the condition that new MRAG-nominated directors be appointed to the Rockwell Board to replace Ben Wolin, Lisa Colleran, John Cooper and Mark Ravich . In view of Mr. Wolin’s subsequent resignation, MRAG still intends to proceed with its nominations of three new, independent directors to replace directors Colleran, Cooper and Ravich as MRAG feels the remaining directors have neglected to exercise a sound, fiscally prudent, successful strategy for Rockwell Medical and its shareholders while the RMTI share price has lost as much as 84% of its value and plunged to an all-time low recently trading at $1.12 per share
MRAG notes that the Rockwell has the worst Governance Quality Score, ranked by Institutional Shareholder Services (ISS). ISS, according to their website, empowers investors and companies and is today the world’s leading provider of corporate governance and responsible investment solutions. As of December 31, 2019, Rockwell Medical’s Governance Quality Score is 10 on a 1 – 10 rating scale. A decile score of 1 indicates lower governance risk, while a 10 indicates highest governance risk. Rockwell’s ISS pillar score for Audit is 10 and for Compensation is 10.
MRAG thinks the debt financing that was approved by the Rockwell directors is not in the best interest of Rockwell shareholders. MRAG believes Rockwell has not been transparent with shareholders regarding the details of the Company’s recent debt financing and amendments to its agreement with Baxter Healthcare by waiting to disclose the details in a future 10-Q, rather than in the 8-K reporting the financing and the amendment. The details missing from the 8-K that Rockwell filed on March 20, 2020, include covenants which are based on Triferic sales targets and the costs of amending the Baxter Agreement.
MRAG questions the business judgement of the Rockwell management and directors. MRAG feels that the decisions the Rockwell Board has made during the last several months have been unwise, have not benefited shareholders and have been driven by not putting their shareholders‘ interest first.
MRAG believes that if the directors interests were aligned with their shareholders interest they would have accepted $15 million in equity priced at the market and refreshed the Board with three new, independent directors, and they would not have consummated the recent debt financing,
completed four additional financings over 14 months including an ATM vehicle still in place,
given up on securing Triferic TDAPA reimbursement efforts as they have stated on their earnings call,
tried to launch Triferic commercially in the Medicare bundled payment,
hired a large sales force to try and sell Triferic in the Medicare bundled payment,
chosen not to commercially launch the FDA approved drug Calcitriol,
compensated themselves with salaries, bonuses and stock options for their lack of performance.
Mr. Khurram Shroff, General Partner of MRAG, stated “In my view, Rockwell’s debt financing is further evidence of the Board’s bad decision making and coupled with their disingenuous attempt to prevent shareholders the opportunity to vote for our three new directors at the annual meeting it clearly shows how badly they are trying to entrench and enrich themselves at the expense of their shareholders. We are focused on stopping the excessive spending on compensation for poor performance and results, improving governance, and bringing much-needed transparency to RMTI shareholders. Shareholders need a Board that puts a premium on practicing good governance, sound decisions, transparency, truth and prudent management of the Company funds. For the sake of all shareholders, we intend to use all options available to us, including litigation, in order to ensure that our slate of directors is considered by the shareholders at the upcoming annual shareholder meeting.”
MRAG is wholly-owned by Canadian, UAE-based businessman Khurram Shroff, who is an award- winning, global banking and finance leader. MRAG focuses on disruptive technologies in the healthcare space and is assisted by expert advisers from three continents who have global financial and strategic networks. Mr. Shroff is focused on investments in companies with innovative technologies that can bring advancement in treatment to patients worldwide. Mr. Shroff is driving an initiative to introduce vital, state-of-the-art, dialysis products and solutions globally. Mr. Shroff views his investment in Rockwell Medical as facilitating this initiative.
No Current Solicitation – 2020 Annual Meeting Not Yet Scheduled
Although we are not currently soliciting stockholders in respect of the 2020 Annual Meeting of Rockwell Medical, Inc.(“Rockwell”), this communication may nevertheless be deemed to be solicitation materials under applicable SEC regulations. Once Rockwell sets the relevant record and meeting dates, MRAG may determine to file relevant materials with the SEC, including a proxy statement on Schedule 14A. STOCKHOLDERS OF ROCKWELL ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING MRAG’S PROXY STATEMENT IF WE DECIDE TO SOLICIT IN OPPOSITION TO MANAGEMENT, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain the documents free of charge at the SEC’s web site. Such documents are not currently available.
Potential Participants in Solicitation
If we determine to solicit stockholders in respect of the 2020 Annual Meeting of Rockwell, MRAG, its members and controlling parties may be deemed to be participants in the solicitation of proxies and information about such parties will be included in any proxy statement we file regarding the 2020 Annual Meeting once Rockwell sets the relevant record and meeting dates.
Forward Looking Statements
Certain information set forth in this presentation contains “forward-looking information”, including “future oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward looking statements). These forward-looking statements are based on current expectations, estimates, forecasts and projections. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MRAG’s control.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause events to differ materially from any expectations or projections of future performance or result expressed or implied by such forward looking statements. These risks include, among other things: (i) market perception regarding MRAG and the viability of the proposed transactions; (ii) the availability of financing for the proposed transaction with Rockwell Medical; and (iii) the recent outbreak of the novel coronavirus and the global impact it may have on financial markets and the life sciences sector.
Although forward-looking statements contained in this presentation are based upon what management of MRAG believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. MRAG undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
CONTACT:
Tien Ma
c/o Redhill Communications
011 49 163 835 8774
Contact:
Thanks Pigeon. That picture was taken by my buddy in Waco. The clerk said it has been selling.
Alright. Just spoke with the clerk at Drug Emporium/Vitamins plus in Waco TX. Ph: 254 772 7250.
Regular Alkame Water ( in the blue bottle ) is now stocked at Drug Emporium/Vitamins Plus.
He said they originally had it on the end cap and it sold well so they moved it to the water shelf. Said it appeared some bottles has sold from there too.. Love it!
insert-text-herehttps://scontent-mia3-2.xx.fbcdn.net/v/t1.0-9/p720x720/89432807_2890084167701351_8908572421779357696_o.jpg?_nc_cat=109&_nc_sid=ca434c&_nc_ohc=a_ozrbL-kvMAX-GCLBA&_nc_ht=scontent-mia3-2.xx&_nc_tp=6&oh=620fbca50c2c5bf5dd146059b3406ba8&oe=5E9F5412
Little help. How do I post the picture?
I just went ahead and bought 250,000 at .0046. Total 500,000.
Thanks NB. Looking forward to this one. You have to love the game as much as the profits to be any good at this.
Jumped in with 250,000 @ .0043/44shares. Threw a thousand bucks at it and will ride it out long term.
Little difficult to figure out the share situation but the 2018 fins seem to be audited so gotta be something going on here.
Rare to find a stock at this price that shows a healthy profit.
If they throw off cash to pay off loans and buy back stock this one could be a biggie.
I would think that they have some tangible demands for this product before moving this way. IMO they have some orders to wholesalers...at least I hope so. LOL.
Agree. That is why they need to assume no insurance proceeds will be coming. Plus getting insurance going forward will be an issue IMO.
Rockwell Replies:
WIXOM, Mich., March 20, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today reiterated that Medical Resource Acquisition Group LLC (MRAG) failed to properly deliver a notice of director nominations under the Company’s Bylaws within the prescribed advance notice period.
While MRAG has continued its attempts to confuse shareholders into believing otherwise, the Company has been abundantly clear in its communications with MRAG and its advisors that MRAG’s three director nominees will not stand for election at the Company’s 2020 annual meeting of stockholders. The Company will also make copies of such correspondence available on our website, https://ir.rockwellmed.com/. The Company continues to advise shareholders to exercise caution in connection with this matter.
Texas building codes do not require fire sprinklers.
MRAG is not going away:
Medical Resource Acquisition Group, LLC (MRAG), an investment company focused on facilitating the advancement of innovative healthcare companies, announces that it remains focused on replacing Rockwell Medical, Inc. (RMTI; NASDAQ) Directors Lisa Colleran, John Cooper and Mark Ravich. MRAG believes Director’s Colleran, Cooper and Ravich have been largely responsible for the destruction in value of the RMTI share price, which under their guidance, or lack thereof, has lost approximately 84% of its value and plunged to an all-time low trading recently at $1.12 per share.
MRAG views the Rockwell Board’s decision to announce in a press release to shareholders that it consummated a debt financing up to $35 million, and that it was a non-dilutive financing done at the urging of shareholders, to be misleading, deceptive and not in the best interest of the shareholders of Rockwell.
Mr. Khurram Shroff, General Partner of MRAG, stated, “To bring on such a huge amount of debt, approximately 32% of the market cap at time of closing, with no current or foreseeable way to pay it down, is not in the best interest of shareholders. For that matter, it is not in the best interest of anyone other than the debt holder and the bank they paid. Furthermore, for management to tell investors in the press release that it is a non-dilutive financing while also stating that the Loan Agreement includes customary warrant coverage is blatantly misleading and deceiving. Warrants are dilutive. The Board and management also left out the important terms of the loan, such as the number of warrants issued and at what strike price, the interest rate and other covenants. We also do not understand why the public offering of common stock in February 2020, done by Cantor Fitzgerald & Co, was required or helped facilitate this Debt financing as the Company has stated. Or why Cantor Fitzgerald & Co were paid for this transaction. This Board’s lack of transparency, and outright attempt to keep shareholders in the dark, is very troubling and we plan to change that once we have our seats on the Rockwell Board.”
Mr. Shroff further stated, “The Rockwell Medical management team and Board of Directors’ failure to provide appropriate governance and truly independent directors on the Board has led to a lack of operational controls, reckless spending and excessive compensation paid to Rockwell executives and directors, resulting in five, highly dilutive financings and incredibly poor stock performance. Shareholders need a Board that puts a premium on practicing good governance, transparency, truth to shareholders and prudent management of the Company funds. Shareholders also must have directors who have purchased and own stock so that directors are aligned with the shareholders best interest, which is not the case with five of the six current Rockwell directors.”
MRAG believes Lisa Colleran, John Cooper and Mark Ravich, who are up for possible reelection at the upcoming Rockwell annual meeting, have been instrumental in overseeing the reckless Board decisions and resulting devastation in value of the RMTI share price. The three directors in MRAG’s view, have been a distraction for the Board and have gone to great lengths to pay themselves excessively while hindering the conception, adoption and execution of a sound, fiscally prudent strategy for Rockwell Medical and its shareholders.
On February 24, 2020, MRAG offered funding of $15 million, for equity priced at-the-market, to Rockwell Medical along with placing three new, highly successful directors on the Rockwell Board in a bid to restructure and reinvigorate the Company and increase its share value. Mr. Shroff believes that as Directors on the Rockwell Board, he, Markus Mueller and Arthur Reynolds will bring new opportunities and new investors into the Company and help facilitate the expansion of its business interests and investment profile worldwide.
MRAG believes Rockwell’s Board of Directors, by attempting to refuse acceptance of MRAG’s slate of Directors after Rockwell confirmed to MRAG in writing that their notice of director nominations was properly delivered under the Company’s Bylaws within the prescribed advance notice period, is trying to suppress the Company shareholders’ right to vote for the directors they feel should be elected to the Company Board. MRAG views this attempt of voter suppression by the Rockwell directors to be an effort to entrench and enrich themselves, and therefore a clear violation of their fiduciary duty to shareholders. MRAG maintains that it correctly submitted its slate of directors for the upcoming annual shareholder meeting and that this was done in accordance with the bylaws of Rockwell Medical and the state laws of Delaware and its discussions with Company representatives. MRAG intends to use all options available to it, including litigation, in order to ensure that their slate of directors is considered by the shareholders at the upcoming annual shareholder meeting.
MRAG is backed by Canadian, UAE-based businessman Khurram Shroff, who is an award- winning, global banking and finance leader. MRAG focuses on disruptive technologies in the healthcare space and is assisted by expert advisers from three continents who have global financial and strategic networks. Mr. Shroff is focused on investments in companies with innovative technologies that can bring advancement in treatment to patients worldwide. Mr. Shroff is driving an initiative to introduce vital, state-of-the-art, dialysis products and solutions globally. Mr. Shroff views his investment in Rockwell Medical as facilitating this initiative.
Link to original letter sent to Rockwell by Medical Acquisitions Resources:
https://www.mragworld.com/rockwelloffer
Wow. The dip hurts on my 3.00 purchase, but I added 1000 shares in2.30 range. Let's have a great conference call today.
Looks like the suitor was a scam per Rockwell letter this morning.
Bought 2,000 shares at 3.00 going into tomorrow's earnings call.
Think the news will be good.
I sure hope not. If adverse stock action must happen I hope it is a straight increase in AS along with a pronouncement that the company will begin a buyback program.
An R/S would be a betrayal of all the stockholders who have supported this company through thick and thin.
Definitely a good sign. The company has said they will be regularly issuing pr's once they get caught up in fins. I think the potential of the company has not been fully recognized due to the self imposed silence.
Cannaribbean is a frozen push up pop with cbd in many flavors that can be made and delivered right from the mfg site in Oregon easily and inexpensively..plus the sales can be over the internet meaning cash sales with no middle men so margins should be good. This should be available soon.
I don't have any more information than anyone else. Just over the last couple of years the management has gone to extraordinary lengths to avoid anything that would "condition" or "pump" the stock.
Hat you pound Kaufmann and basically call him a rascal with no supporting evidence. Why? Frankly the only one who pumps is you. You told everyone you were buying shares at .0014 and then sold and disappeared. Now you are back because the pps has dropped again.
I did visit the facility in person and was welcomed and toured the operation with Eakle.
I neither asked for nor was offered any inside info. They are very serious about maintaining proper arms length and also protecting their clients who require anonymity as to the copacking arrangements.
Could a R/S happen? Yes. But usually you see an R/S when there is a change in ownership or business direction. What good would a R/S do anyone? It would mean the company is not successful in what it has been doing..why would anyone lend money to a company that just admitted it can't make it?
My belief is that the only way forward that makes any sense is to buy back shares.
Since you left Hat I have visited Gervais. You have it completely wrong about Kaufmann.
Listened to the Conference call this morning. Have to say it was excellent. CEO Stewart Paul certainly a huge improvement over Chioni IMO. Went ahead and picked up 2,000 shares this morning.
Highlight is the 75% adoption rate of facilities that did trials with Triferic. Approx $100,000 in sales in qtr 3. Seems to be just getting started.
yep. Craig says the rest of the filings should come much faster. It is blueberry season and Highdrates are hitting shelves all over the USA. New flavors and damn good taste.
News out! Revs for May over $200,000.
Except that the ss is only 68 milly..no dilution reported as of now.
If the sales are stronger than expected and the ss stays this low this one will jump.
I think the comparison to rmhb is valid, but the public's acceptance of hemp/cbd is much more widespread and retailers are no longer resisting stocking them nearly as much.
Good point.
However..when you deal with large distributors, and especially AB's they check it out. They won't do business with shams.
This is a different product and the consumer market is much larger.
I have seen the video of their copacker in Vegas cranking out shit loads of product..and comments that half of it was going directly on trucks.
If the fins come out and the margins have increased and the sales are strong this ticker will explode..if their cash flow is adequate to where they don't have to dilute it will climb quick.
8k's are fluff?
Yes and that Share Structure is holding at 68 milly. Should be dropping some fins soon.
Just bought 50k more shares. This company is quietly building one heck of a distribution network.
Kelly Distro in beast mode. They will be selling kona's at this show. Should sell a lot if the response at the SIC show 2 weeks ago is any indication.
Mary's Mixers showing nice growth in it's retail outlets.
Gold Leaf Distribution in Florida posting that they are stocking new stores daily.
1400+ But I am quoting from the company facebook page.
Kona Gold facebook page post says their family is growing fast!